USV Pharma is in advanced talks to acquire an 85% stake in Wellbeing Nutrition at a Rs 1,600 crore valuation, marking a major move into India’s fast-growing consumer health and supplements market.
Kashiv BioSciences has signed an exclusive licensing and supply agreement with Intas Pharmaceuticals to commercialize a complex peptide product across Europe, the UK, and India, expanding its global footprint.
Piramal Pharma has partnered with Blue-Zone Technologies to recycle waste anaesthetic gases through its subsidiary Piramal Critical Care, aiming to cut environmental impact while ensuring continued access to essential anaesthesia products.
Gujarat Chief Minister Bhupendra Patel praised the Union Budget 2026-27, highlighting significant allocations for the MSME, pharma, and semiconductor sectors. The budget aims to strengthen Gujarat’s industrial growth and improve liquidity.
Zydus Lifesciences has received tentative FDA approval for dapagliflozin tablets in 5 mg and 10 mg strengths. The drug, used to treat type 2 diabetes, will be manufactured at the company’s SEZ facility in Ahmedabad.
.png)
Sun Pharma is working to stabilize its US generics business as manufacturing issues ease, while pushing innovation-led growth, specialty launches, and preparing for the day-one launch of generic semaglutide in India.
BPL Medical Technologies made a strong impact at the 78th Annual Conference of the diagnostics, and women’s health technologies...
Healthcare major Cupid Limited has secured CE certification for its HIV 1&2 and Hepatitis B test kits under EU IVDR, unlocking access to regulated European and global diagnostics markets.
RPG Life Sciences supports the India–EU FTA, highlighting the tariff reduction on pharmaceuticals. The move boosts India's pharma competitiveness, global exports, and access to affordable medicines.
India’s India-EU FTA opens access to a $572.3 billion pharma and MedTech market, cutting tariffs and boosting exports, jobs, and manufacturing across key Indian states.
.jpg)
.jpg)
, CDSCO.jpg)